Urbanization and policy support are two favorable factors to promote the development of pharmaceutical industry. The steady progress of urbanization will be a powerful driving force for the expansion of the pharmaceutical market and the rapid growth of the industry. The introduction of the new medical reform plan will greatly improve the coverage of medical insurance, enable more people to enjoy affordable medical services, and stimulate the growth of drug and medical device consumption. Supporting policies and a large amount of investment will bring new development opportunities for the pharmaceutical industry.
Under this background, SF Medical Co., Ltd. will take on the role of a bridge between more pharmaceutical manufacturers and terminal markets such as hospitals and pharmacies, and participate in this highly competitive market. Established in 1995, SF Medical Co., Ltd. is a state-owned joint venture with 15 years, engaged in drug sales agency management and capable of providing logistics and distribution. It is the earliest pharmaceutical enterprise with GSP certification and ISO900 1 quality system certification in China, mainly engaged in Chinese patent medicines, chemical preparations, chemical medicines, antibiotics, biochemical medicines, biological products, psychotropic drugs of the second kind (preparations), protein assimilation preparations, peptide hormones and medical devices.
This paper expounds the development status and trend of pharmaceutical commercial enterprises at home and abroad, as well as the healthy development marketing strategy formulated by SF Medical Co., Ltd., a leading domestic pharmaceutical commercial enterprise, in order to help more SF Medical Co., Ltd. better adapt to the changing pharmaceutical industry environment.
Keywords: SF company, medicine, marketing strategy